Giulianelli, Giacomo https://orcid.org/0009-0005-1895-689X
Cocconcelli, Elisabetta
Fiorentù, Giordano
Bernardinello, Nicol
Balestro, Elisabetta
Spagnolo, Paolo
Article History
Received: 27 January 2025
Accepted: 2 April 2025
First Online: 5 May 2025
Declarations
:
: Elisabetta Cocconcelli declares consulting fees from Boehringer Ingelheim and Chiesi. Elisabetta Balestro declares consulting fees from Boehringer Ingelheim and Roche, speaker fees from Boehringer Ingelheim, and has been a trial investigator for Boehringer Ingelheim and Roche. Paolo Spagnolo reports grants from PPM Services, Roche, Boehringer Ingelheim and Chiesi; consulting fees from PPM Services and Novartis; honoraria from Boehringer Ingelheim; support for attending meetings from PPM Services; participation on a Data Safety Monitoring Board or Advisory Board from AstraZeneca, Trevi, Merck, Galapagos, Novartis and Structure Therapeutics. His wife is an employee of AstraZeneca. Giacomo Giulianelli, Giordano Fiorentù and Nicol Bernardinello have nothing to disclose. Nicol Bernardinello and Paolo Spagnolo are Editorial Board members of Pulmonary Therapy. Nicol Bernardinello and Paolo Spagnolo were not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.